| Phase 4 |
| NCT04262206 |
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults |
Duke University |
Recruiting |
2026-09-01 |
| NCT07604896 |
Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through… |
First Affiliated Hospital of Wenzhou Medical University |
Recruiting |
2026-05-22 |
| NCT07485283 |
Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia |
Tor Biering-Sørensen |
Recruiting |
2026-05-04 |
| NCT07284290 |
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body… |
Virginia Commonwealth University |
Recruiting |
2026-03-06 |
| NCT05590637 |
Comparing Antipsychotic Medications in LBD Over Time |
The University of Texas Health Science Center at San Antonio |
Recruiting |
2025-09-09 |
| NCT06093126 |
Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial |
Nova Scotia Health Authority |
Recruiting |
2025-02-21 |
| NCT05514106 |
MIBG in Aging and Neurologic Disorders |
Mayo Clinic |
Enrolling by Invitation |
2026-07-30 |
| NCT00950430 |
Imaging of Brain Amyloid Plaques in the Aging Population |
Mayo Clinic |
Enrolling by Invitation |
2026-06-23 |
| NCT01453127 |
DaTSCAN Imaging in Aging and Neurodegenerative Disease |
Mayo Clinic |
Enrolling by Invitation |
2026-03-10 |
| NCT05586750 |
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy |
Monash University |
Active, Not Recruiting |
2025-05-22 |
| NCT06662526 |
Lithium for Prevention of Cognitive Declining in Mood Illnesses |
University of Chile |
Not Yet Recruiting |
2024-10-30 |
| Phase 3 |
| NCT07083154 |
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
Recruiting |
2026-09-02 |
| NCT07724132 |
An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic… |
University College, London |
Recruiting |
2026-07-23 |
| NCT07602582 |
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM… |
Eli Lilly and Company |
Recruiting |
2026-07-07 |
| NCT07422857 |
Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment… |
JYAMS PET Research & Development Limited |
Recruiting |
2026-02-20 |
| NCT05397639 |
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type |
Suven Life Sciences Limited |
Recruiting |
2026-01-12 |
| NCT07234695 |
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down… |
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
Recruiting |
2026-01-12 |
| NCT06534723 |
Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate… |
Sichuan Jishengtang Pharmaceutical Co., Ltd. |
Recruiting |
2025-12-29 |
| NCT07251023 |
Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia |
Bigespas LTD |
Recruiting |
2025-12-10 |
| NCT03848312 |
Preventing Alzheimer's With Cognitive Training |
University of South Florida |
Active, Not Recruiting |
2026-08-24 |
| NCT06384573 |
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease |
Washington University School of Medicine |
Active, Not Recruiting |
2026-07-27 |
| NCT07095465 |
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis |
ACADIA Pharmaceuticals Inc. |
Enrolling by Invitation |
2026-07-24 |
| NCT05532657 |
ACHIEVE Brain Health Follow-Up Study |
Johns Hopkins University |
Active, Not Recruiting |
2026-07-21 |
| NCT05508789 |
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's… |
Eli Lilly and Company |
Active, Not Recruiting |
2026-07-16 |
| NCT05738486 |
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early… |
Eli Lilly and Company |
Active, Not Recruiting |
2026-06-18 |